|
Status |
Public on Apr 19, 2018 |
Title |
BMI1 drives metastasis of prostate cancer in Caucasian and African-American men and is a potential therapeutic target: hypothesis tested in race-specific models |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by RT-PCR
|
Summary |
MDA-PCa2b cells were treated with PCT-209 or control (DMSO) for 24h and subjected to the qRT-PCR based microarray analysis (Qiagen, Germantown, MD).
|
|
|
Overall design |
qPCR gene expression profiling. Metaststic African american prostate cancer cell line MDA-Pca2b cells were treated with BMI-1 inhibitor PTC-209 or control as indicated in the summary. Equal amount total RNA from Treated and control was used for gene expression analysis.
|
|
|
Contributor(s) |
Saleem M, Beigh FH |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Apr 18, 2018 |
Last update date |
Apr 20, 2018 |
Contact name |
Mohammad Saleem |
Organization name |
University of Minnesota
|
Department |
Urology
|
Lab |
Molecular Therapeutics and Cancer Health Disparity
|
Street address |
2231 6th St SE
|
City |
Minneapolis |
State/province |
Mn |
ZIP/Postal code |
55455 |
Country |
USA |
|
|
Platforms (1) |
GPL24904 |
RT² Profiler PCR Array Human Prostate Cancer |
|
Samples (2) |
|
Relations |
BioProject |
PRJNA450790 |